SOTIO's Dendritic Cell Vaccines Have Promise In Ovary And Lung Cancer

 
• By John Davis

Interim Phase II data has shown that SOTIO's dendritic cell-based cancer vaccine candidates have efficacy in patients with ovarian cancer and non-small cell lung cancer.

Plant
New cancer vaccines may be on the horizon • Source: Shutterstock

More from Clinical Trials

More from R&D